Literature DB >> 7334085

Autoimmunity in ocular and generalised myasthenia gravis.

M J Garlepp, R L Dawkins, F T Christiansen, J Lawton, G Luciani, J McLeod, J Bradley, G Genkins, C S Teng.   

Abstract

Restricted ocular myasthenia gravis (OMG) and generalised myasthenia gravis (GMG) have been shown to differ in a number of respects. In OMG, antiacetylcholine receptor, antistriational and antinuclear antibodies were rare relative to their frequency in GMG. In contrast, antithyroid antibodies and a history of thyroid disease were much more prevalent in OMG than in GMG, OMG was not associated with the female predominance seen in GMG and appeared to be relatively common in some races rather than others. It is suggested that different pathogenetic mechanisms are responsible for these two forms of MG.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334085     DOI: 10.1016/0165-5728(81)90035-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  Concomitant euthyroid Graves' ophthalmopathy and isolated ocular myasthenia gravis.

Authors:  H Raef; M Ladinsky; R Arem
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

2.  Antibodies against saline-soluble components of skeletal muscle in myasthenia gravis.

Authors:  A Komiyama; I Kamo; S Furukawa; S Akazawa; K Hirayama; E Satoyoshi
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

3.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16

4.  Susceptibility to murine experimental autoallergic myasthenia gravis: the role of antibody specificity.

Authors:  A L Marzo; M J Garlepp; M Schon-Hegrad; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

5.  Strong association of HLA BW46 with juvenile onset myasthenia gravis in Hong Kong Chinese.

Authors:  B R Hawkins; W Y Chan-Lui; E K Choi; A Y Ho
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-05       Impact factor: 10.154

6.  HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.

Authors:  B R Hawkins; M S Ip; K S Lam; J T Ma; C L Wy; R T Yeung; R L Dawkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-03       Impact factor: 10.154

7.  Ocular myasthenia gravis: controversies and updates.

Authors:  Sui H Wong; Saif Huda; Angela Vincent; Gordon T Plant
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

8.  Graves' disease: associated ocular myasthenia gravis and a thymic cyst.

Authors:  S R Peacey; P E Belchetz
Journal:  J R Soc Med       Date:  1993-05       Impact factor: 18.000

9.  Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis.

Authors:  Giovanna Rotondo Dottore; Marenza Leo; Roberta Ricciardi; Michelangelo Maestri; Ilaria Bucci; Marco Lucchi; Franca Melfi; Melania Guida; Anna De Rosa; Loredana Petrucci; Ilaria Ionni; Giulia Lanzolla; Francesca Nicolì; Michele Mantuano; Debora Ricci; Francesco Latrofa; Stefano Mariotti; Claudio Marcocci; Michele Marinò
Journal:  Eur Thyroid J       Date:  2020-10-06

10.  Ocular myasthenia gravis in a setting of thyrotoxicosis.

Authors:  Sarabjeet Chhabra; B C Pruthvi
Journal:  Indian J Endocrinol Metab       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.